Author:
Murugan Kalaivani,Ostwal Vikas,Carvalho Maria Deo,D’souza Anita,Achrekar Meera S.,Govindarajan Shrinivasan,Gupta Sudeep
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A et al (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352(26):2696–2704
2. Yamagiwa K, Shigematsu T, Takeda K, Shirai M, Amemori K, Sunda K, et.al (2013) Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy. [cited 2014 Feb 17]; 40(2):161–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24712132
3. Takeda K, Shigematsu T, Shirai M, Yamagiwa K, Amamori K, Sunda K, et.al (2012) Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy. Gan To Kagaku Ryoho [abstract]. [cited 2015 Feb 17]; 39(1):74–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23268906
4. Hoesly JF, Baker SG, Gunawardane ND, Cotliar JA (2011) Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature. JAMA Dermatol 147(12):1418–1423, cited Feb 17
5. Saif M (2011) Capecitabine and hand-foot syndrome. Expert Opin Drug Saf [abstract]. [cited 2015, Feb 27]; 10(2):159-169. doi: 10.1517/14740338.2011.546342
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献